SEC 13F Intelligence

Canada Life Assurance Co / EW

Canada Life Assurance Co’s Edwards Lifesciences Corp Position

Does Canada Life Assurance Co own Edwards Lifesciences Corp (EW)? Yes382.9K shares worth $31M (+0.06% of its 13F portfolio) as of Q1 2026, down from 390.4K shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
382.9K
% of Portfolio
+0.06%
Quarters Held
29
currently held

Position History EW

Reported value by quarter
Q1 ’19: $30MQ1 ’19Q2 ’19: $51MQ3 ’19: $62MQ4 ’19: $83MQ1 ’20: $70MQ1 ’20Q2 ’20: $76MQ3 ’20: $86MQ4 ’20: $86MQ1 ’21: $72MQ1 ’21Q2 ’21: $70MQ3 ’21: $79MQ4 ’21: $78MQ1 ’22: $76MQ1 ’22Q2 ’22: $50MQ3 ’22: $42MQ4 ’22: $47MQ1 ’23: $53MQ1 ’23Q2 ’23: $48MQ3 ’23: $44MQ4 ’23: $49MQ1 ’24: $61MQ1 ’24Q2 ’24: $64MQ3 ’24: $47MQ4 ’24: $50MQ1 ’25: $39MQ1 ’25Q2 ’25: $43MQ3 ’25: $29MQ4 ’25: $33MQ1 ’26: $31MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026382.9K$31M+0.06%
Q4 2025390.4K$33M+0.06%
Q3 2025369.4K$29M+0.04%
Q2 2025544.4K$43M+0.07%
Q1 2025538.5K$39M+0.07%
Q4 2024675.8K$50M+0.09%
Q3 2024716.7K$47M+0.08%
Q2 2024689.1K$64M+0.12%
Q1 2024634.9K$61M+0.12%
Q4 2023644.1K$49M+0.11%
Q3 2023640.9K$44M+0.11%
Q2 2023509.2K$48M+0.11%
Q1 2023638.7K$53M+0.13%
Q4 2022622.8K$47M+0.12%
Q3 2022511.0K$42M+0.12%
Q2 2022529.2K$50M+0.13%
Q1 2022608.5K$76M+0.16%
Q4 2021606.4K$78M+0.16%
Q3 2021696.3K$79M+0.18%
Q2 2021678.4K$70M+0.16%
Q1 2021870.3K$72M+0.18%
Q4 2020945.8K$86M+0.16%
Q3 20201.08M$86M+0.19%
Q2 20201.10M$76M+0.17%
Q1 2020366.5K$70M+0.19%
Q4 2019358.2K$83M+0.18%
Q3 2019280.2K$62M+0.15%
Q2 2019277.3K$51M+0.12%
Q1 2019159.2K$30M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canada Life Assurance Co’s full portfolio or all institutional holders of EW.